Source: International Congress 2016 – New signalling pathways in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Elena S. Lebedeva (St. Petersburg, Russian Federation), Elena S. Lebedeva, Natalija A. Kuzubova, Olga N. Titova, Ivetta V. Dvorakovskaya, Elena A. Surkova. Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model. Eur Respir J 2016; 48: Suppl. 60, 4023

Member's Comments

No comment yet.

Related content which might interest you: A short-term model of COPD identifies a role for mast cell tryptase Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 T lymphocytes in cigarette-smoke induced-emphysema and bronchial remodelling Source: International Congress 2016 – Mechanisms of disease Year: 2016 Autoimmune induction of a COPD-like inflammatory phenotype in mice Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 The effect of lipopolysaccharide-contaminated ovalbumin on airway inflammation and remodeling in a chronic murine asthma model Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Galectin-9 attenuates elastase-induced emphysema by reducing neutrophil chemotaxis in mice Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Immunohistochemical study on changes of mast cell populations during allergic airway inflammation in mice using HDM model Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 The role of IL-17 producing NK cells and other innate immune cells in poly(I:C) triggered exacerbation of experimental asthma Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 IL-25 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma model Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Treatment: how does inflammatory phenotype influence response to treatment in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Acid sphingomyelinase deficiency improves lung function in allergen-induced asthma in mice Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Effect of human neutrophil proteases on ex vivo small airway function Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung Year: 2013 Repeated lipopolysaccharide stimulation causes corticosteroid insensitive inflammation in lung via phosphoinositide-3-kinase δ signaling Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Nociceptin modulates the inflammatory immune microenvironment in a conventional murine model of asthma Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 PI3Kδ inhibition confer efficacy in experimental models of allergic airway inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Synergistic suppression of T cell-induced eosinophilia by CTLA4-Ig and glucocorticoid in murine asthma model Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 D-tryptophan influences allergic airway inflammation and Th2 immune responses Source: International Congress 2015 – Asthma mechanisms and management Year: 2015 The effect of anti-IL-33 antibody and soluble ST2 in a murine model of allergic asthma Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013